Focus: Tailor Bio is a UK-based cancer biotechnology company focused on oncology treatments. The company is in early-stage development with 54 active job openings.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Hot — 31 jobs added in 30d
Net +29 (31 new, 2 removed). Aggressive expansion phase.
Tailor Bio is a high-risk, high-upside early-stage play best suited for scientists and technologists willing to bet on unproven science in exchange for equity and operational influence.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Tailor Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Tailor Bio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub